Marrone Bio Innovations

Marrone Bio Innovations, Inc., a biopesticide company, engages in the discovery, development, and marketing of natural products for weed, pest, and plant disease management. Its products include Regalia, a product that protects food and ornamental crops from fungal and bacterial diseases; GreenMatch EX, a post-emergence herbicide for burndown weed control for organic growers; and GreenMatch, a burndown herbicide that controls various annual and perennial weeds. The company also offers insecticides, herbicides, and products for controlling invasive zebra and quagga mussels in waterways. In addition, it finds naturally occurring microorganisms from habitats and develops them into products for controlling insects, weeds, nematodes, and plant diseases. The company provides its products online. Marrone Bio Innovations, Inc. was founded in 2006 and is based in Davis, California.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Pro Farm Group, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. Its products include Grandevo Insecticide, Majestene Nematicide, Regalia Fungicide, Stargus Fungicide, Venerate Insecticide, Amplitude Fungicide, Regalia Rx Plant Health, Zelto Nematicide, Zequanox Molluscicide and Haven. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Raleigh, NC.

Great Ajax

Where Food Comes From Inc

The AgTech industry has been undergoing a high degree of M&A, resulting in very few publicly traded AgTech stocks remaining available.

4 Microcaps In The High Mergers And Acquisitions AgTech Space

President and CFO James Boyd to Retire from the Company; Search Process for New CFO Underway President and CFO James Boyd to Retire from the Company; Search Process for New CFO Underway

Marrone Bio Innovations Announces Plans for CFO Succession

PERGAMINO, Argentina and DAVIS, Calif., Sept.  15, 2020  (GLOBE NEWSWIRE) -- Rizobacter, a subsidiary of Bioceres Crop Solutions Corp. (NYSE: BIOX) and global leader in sustainable solutions for agriculture, and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced the signing of an exclusive agreement to distribute a foliar fertilizer and plant health technology in Argentina, Uruguay, Paraguay and Bolivia.

Rizobacter and Marrone Bio Innovations form a Strategic Alliance to Deploy Novel Plant Health and Crop Nutrition Technology in South America

DAVIS, Calif., Sept.  10, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the H.C. Wainwright 22nd Annual Global Investment Conference taking place virtually September 14 – 16, 2020.

Marrone Bio Innovations to Present at H.C. Wainwright 22nd Annual Global Investment Conference

DAVIS, Calif., Aug.  20, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio” or the “Company”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today announced that management will present at the LD 500 virtual investor conference, hosted by LD Micro and taking place virtually September 1 – 4, 2020.

Marrone Bio Innovations to Present at LD Micro 500 Virtual Investor Conference

Marrone Bio Innovations, Inc. (MBII) Kevin Helash on Q2 2020 Results - Earnings Call Transcript

Second-Quarter Revenue Increased 74% to Record $12.2 Million

Marrone Bio Innovations, Inc. Reports Second Quarter and First Half 2020 Financial Results

Marrone Bio Innovations (NASDAQ: MBII) announces its next round of earnings this Monday, August 10.

Earnings Outlook For Marrone Bio Innovations

TORONTO and DAVIS, Calif., Aug.  06, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, and Vive Crop Protection, a leader in Precision Chemistry solutions and owner of the patented Allosperse® technology, announced an agreement that will provide a suite of ground-breaking products for U.S. growers that combine a leading biological with proven conventional chemistry utilizing the unique Allosperse Delivery System.

Vive Crop Protection and Marrone Bio Innovations join forces to bring next-generation crop protection solutions to growers

DAVIS, Calif., Aug.  04, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place August 11 to 13, 2020.

Marrone Bio Innovations to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12th

Company Concurrently Confirms August 3rd Start Date for Incoming Chief Executive Officer and Director Kevin Helash Company Concurrently Confirms August 3rd Start Date for Incoming Chief Executive Officer and Director Kevin Helash

Marrone Bio Innovations to Report Second Quarter 2020 Results on Monday, August 10th at 4:30 p.m. Eastern Time

Agricultural Industry Veteran Brings Extensive Experience in Global Markets and Biological Solutions Agricultural Industry Veteran Brings Extensive Experience in Global Markets and Biological Solutions

Marrone Bio Appoints Kevin Helash as Chief Executive Officer

Newly Approved Stargus® Expands Company Footprint Newly Approved Stargus® Expands Company Footprint

Marrone Bio Innovations’ Regalia® is Top Biofungicide Brand in California

DAVIS, Calif., June  22, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that it received notice from The Nasdaq Stock Market, LLC ("Nasdaq") on June 19, 2020 indicating that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market.

Marrone Bio Innovations Regains Compliance with Nasdaq Minimum Bid Price Requirement

DAVIS, Calif., June  09, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced the signing of an exclusive commercial agreement with UPL to distribute REGALIA® MAXX Fungicide in the Republic of South Africa.

Marrone Bio Innovations and UPL Sign Exclusive Distribution Agreement for REGALIA® MAXX in the Republic of South Africa

DAVIS, Calif., May  14, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced today that REGALIA® MAXX biofungicide received the first approval for indoor and outdoor use on cannabis and hemp in Canada.

Marrone Bio Innovations’ REGALIA® MAXX Receives First Approval for Use on Cannabis and Hemp in Canada

Marrone Bio Innovations, Inc. (MBII) Pam Marrone on Q1 2020 Results - Earnings Call Transcript

DAVIS, Calif., April  30, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (Nasdaq: MBII) (the “Company” or “Marrone Bio”) an international leader in sustainable bioprotection and plant health solutions, has signed a warrant exchange agreement with existing institutional investors that immediately reduces the total number of outstanding warrants by approximately 35%, from 52.6 million to 36.5 million.

Marrone Bio Announces Warrant Exchange Agreement

Final Candidate Identified from CEO Search Efforts Final Candidate Identified from CEO Search Efforts

Marrone Bio Innovations Provides Corporate Update

Company Expects Full Loan Forgiveness Under Terms; Funds to be Used to Retain Workforce During Critical Spring Growing Season for U.S. Farmers Company Expects Full Loan Forgiveness Under Terms; Funds to be Used to Retain Workforce During Critical Spring Growing Season for U.S. Farmers

Marrone Bio Innovations Secures $1.7 Million Loan Under Paycheck Protection Program Provision of CARES Act

Bio-Based Plant Health Product Pacesetter™ Proven to Boost Yield and ROI to Farmers Bio-Based Plant Health Product Pacesetter™ Proven to Boost Yield and ROI to Farmers

Marrone Bio Announces Introduction of New Synergistic Plant Health Product Available to Corn, Soybean and Wheat Growers

Form S-1 Resale Registration Statement Permits Resale of Common Stock from Prior Financing Transactions; No new securities are being offered Form S-1 Resale Registration Statement Permits Resale of Common Stock from Prior Financing Transactions; No new securities are being offered

Marrone Bio Innovations Announces Effectiveness of Form S-1 Resale Registration Statement

DAVIS, Calif., March  23, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health products, announced today that its Jet-Oxide® 15% post-harvest sanitizer and industrial disinfectant product is now allowed by the U.S. EPA for use against human coronaviruses to sanitize industrial food and agricultural hard surfaces. The allowed use was based on a study conducted by the EPA with Human Coronavirus Strain 229E (one of the viruses associated with human colds) on the effectiveness of spreading of diseases on hard surfaces.

Marrone Bio Innovations’ Jet-Oxide® 15% Sanitizer Product is Allowed by the U.S. EPA for Use on Industrial Hard Surfaces for Human Coronaviruses

Marrone Bio Innovations, Inc. (MBII) Pam Marrone on Q4 2019 Results - Earnings Call Transcript

DAVIS, Calif., March  09, 2020  (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), a leading provider of effective and environmentally responsible pest management and plant health products, announced today the signing of a commercial agreement with Anasac Chile S.A. to develop and distribute GRANDEVO® Bioinsecticide and VENERATE® Bioinsecticide in Chile.

News for Marrone Bio Innovations Stock (MBII)